Ttk Healthcare Limited
₹1,115.40
-1.67%
Delayed · cached 15 min
Fair value analysis
TTKHLTCARE
Ttk Healthcare Limited
₹1,134.40
Close used for this calculation
₹661.52Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
38/100
Quality radar
Consensus fair value
₹661.52
Above FV▼ -41.7% against the close used
Model range ₹70.31 – ₹990.18
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹70.31Fair value₹661.52Bull₹990.18
FairClose
52-week traded range
52W low ₹739.6052W high ₹1,192.60
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Ttk Healthcare Limited closed at ₹1,134.40, 71.5% above the consensus fair value of ₹661.52 drawn from 9 valuation models.
Financial DNA score 38/100 — Average. P/E of 20.6x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹832.03
-26.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=7.2%, r=10%, tg=3%, n=10yr
Graham Number
₹990.18
-12.7%
√(22.5 × EPS × BVPS)
EPS=46.48, BVPS=937.52 · outside Graham range (P/E 20.6, P/B 1.2) — asset-light, treat as a rough floor
Graham Formula
₹988.36
-12.9%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=7.2%, FD=7%
P/E Fair Value
₹618.18
-45.5%
EPS × 13.3x (sector P/E)
EPS=46.48, Sector P/E=13.3x
Peter Lynch (PEG)
₹334.66
-70.5%
EPS × Growth% (PEG = 1 is fair)
EPS=46.48, g=7.2%
EV/EBITDA
₹325.35
-71.3%
(EBITDA × 13.6x − Net Debt) ÷ Shares
EBITDA=350M
Book Value (P/B)
₹70.31
-93.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=937.52, ROE=6.3%, g=6%, r=10%
Reverse DCF
₹1,134.40
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 9.8% | Historical: 7.2%
Margin of Safety
₹642.89
-43.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=857.19, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.